000 01587 a2200445 4500
005 20250514233016.0
264 0 _c20050919
008 200509s 0 0 eng d
022 _a1526-8209
024 7 _a10.3816/cbc.2005.n.015
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHudis, Clifford A
245 0 0 _aWeekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life.
_h[electronic resource]
260 _bClinical breast cancer
_cJun 2005
300 _a132-42 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAnemia
_xchemically induced
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aEpoetin Alfa
650 0 4 _aErythropoietin
_xadministration & dosage
650 0 4 _aFatigue
650 0 4 _aFemale
650 0 4 _aHematinics
_xadministration & dosage
650 0 4 _aHemoglobins
_xanalysis
650 0 4 _aHumans
650 0 4 _aInjections, Subcutaneous
650 0 4 _aMiddle Aged
650 0 4 _aProspective Studies
650 0 4 _aQuality of Life
650 0 4 _aRecombinant Proteins
650 0 4 _aSeverity of Illness Index
650 0 4 _aTreatment Outcome
700 1 _aVogel, Charles L
700 1 _aGralow, Julie R
700 1 _aWilliams, Denise
773 0 _tClinical breast cancer
_gvol. 6
_gno. 2
_gp. 132-42
856 4 0 _uhttps://doi.org/10.3816/cbc.2005.n.015
_zAvailable from publisher's website
999 _c15658479
_d15658479